SABS

Companies
NASDAQ
Sab Biotherapeutics Inc.
Health Care
Price Chart
Overview

About SABS

sab biotherapeutics is a clinical-stage biopharmaceutical development company using its novel immunotherapy platform to produce life-saving therapies.

Market Cap
$27.2M
Volume
139.9K
Avg. Volume
80.5K
P/E Ratio
-0.6879562
Dividend Yield
0.00%
Employees
69.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Risk & Correlation Analysis
Market Correlation
0.48
Low Correlation
Volatility
High (1.00)
Relative to market

Macro Factor Sensitivities

Interest Rates
Low Sensitivity
Inflation
Low Sensitivity
GDP Growth
High Sensitivity
Liquidity
High Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for SABS.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, SABS shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$27.2M
Volume139.9K
P/E Ratio-0.69
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 20, 2025
Related Securities

PortfolioPilot Analysis

Get AI-powered insights on how SABS fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025